Tag:
Matrixx Labs
Latest Headlines
Latest Headlines
Supremes question Matrixx's disclosure arguments
We'll have to wait to hear arguments on the Supreme Court cases accepted yesterday. But while we were talking about those cases, which involve prescription data-mining and drug-discount litigation,
When can investors sue over side-effect disclosures?
When the U.S. Supreme Court hears a Matrixx Labs appeal in a class-action shareholder suit, it could give drugmakers some real guidance about disclosing drug side effects to investors. Matrixx
